Biogen , in its Securities and Exchange Commission quarterly report for the period ending June 30 , said it had earned $ 6.1 million from Avonex sales during the drugs first six weeks on the market .
<response> <organization>Biogen</organization> , in its <organization>Securities and Exchange Commission</organization> quarterly report for the period ending June 30 , said it had earned $ 6.1 million from <misc>Avonex</misc> sales during the drugs first six weeks on the market . </response>